November 2008 - Page 49 of 76

MondayNov 03, 2008 5:43 am

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC)

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC), a diversified biopharmaceutical company, is focused on discovering, developing, and commercializing innovative mechanism-targeted drugs to treat human cancers and other serious disorders. The company’s strategic goal is to discover and develop oral anticancer agents that target the cell cycle with the intent to slow the growth of tumors or even shrink their size while enhancing the patient’s quality of life. For further information, visit the Company's web site at www.cyclacel.com.

MondayNov 03, 2008 5:43 am

SuperGen, Inc. (NASDAQ: SUPG)

SuperGen, Inc. (NASDAQ: SUPG) is focused on building a global, sustainable business by developing and commercializing new drug candidates for oncologists, hematologists, and their patients. The company’s staff is made up of talented individuals who recognize the incredible challenges of drug development. Although some work along and other on teams, each employee brings a distinct perspective to his or her job and is focused on the goal of bringing better products to cancer patients in need. For further information, visit the Company's web site at www.sunesis.com.

MondayNov 03, 2008 5:43 am

CV Therapeutics, Inc.’s (NASDAQ: CVTX)

CV Therapeutics, Inc.’s (NASDAQ: CVTX) primary focused is on applying molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases. The company is devoted to discovering new solutions for the unmet medical needs of patients. By emphasizing on discovery science and small molecule therapeutics, the company’s drug candidates are usually able to be produced by conventional pharmaceutical manufacturing methods. For further information, visit the Company's web site at www.cvt.com.

MondayNov 03, 2008 5:42 am

Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS)

Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS), an emerging biopharmaceutical company, has focused their efforts on creating new medicines designed to improve the lives of patients diagnosed with cancer. The company is currently building a pipeline of drugs that selectively block vital mechanisms necessary for tumor growth and survival. Sunesis recognizes that the fight against cancer is an enormous mission that requires an integrated approach and innovation. For further information, visit the Company's web site at www.sunesis.com.

MondayNov 03, 2008 5:42 am

Curis, Inc. (NASDAQ: CRIS)

Curis, Inc. (NASDAQ: CRIS), a drug development company, is focused on utilizing its innovative signaling pathway drug technologies to discover new targeting small molecule drug candidates for cancer. Through the expansion of its drug development efforts in the field of cancer, the company is building upon its previous experiences in targeting signaling pathways to develop next generation targeted cancer therapies. For further information, visit the Company's web site at www.curis.com.

MondayNov 03, 2008 5:42 am

Stroud Resources Ltd. (TSX: SDR CN)

Stroud Resources Ltd. (TSX: SDR CN), an exploration company focused on the discovery and exploration of silver and gold deposits, is completely debt free and has yearly cash flow of approximately $200,000 from its 3.75% interest in six natural gas and gas condensate wells. Currently, the company has two gold properties in Ontario Canada, and two silver projects in Mexico. The Hislop gold project located in Timmins Ontario with indicated resources of 102,750 oz. and the Santo Domingo Silver project based in Mexico are both 100% owned by Stroud Resources. For further information, visit the Company's web site at www.stroudresourcesltd.com.

MondayNov 03, 2008 5:41 am

CuraGen Corporation (NASDAQ: CRGN)

CuraGen Corporation (NASDAQ: CRGN), a biopharmaceutical company, is devoted to improving the lives of patients by developing pharmaceutical products that address medical needs that are currently unmet. The company’s therapeutics are based on the research of novel drug targets and mechanisms that are believed to play a role in underlying diseases. Through its efforts, CuraGen has utilized this research and understanding to develop a pipeline of protein, antibody, and antibody-drug conjugate drugs. For further information, visit the Company's web site at www.curagen.com.

MondayNov 03, 2008 5:41 am

Strathmore Minerals Corp. (TSX: STM CN)

Strathmore Minerals Corp. (TSX: STM CN) is focused on becoming a leading uranium producer in the United States. Their efforts are concentrated on the acquisition and development of advanced uranium projects in the two largest uranium producing regions in the United States: the Gas Hills Uranium District in Wyoming and the Grants Mineral District, New Mexico, but were abandoned by the major uranium mining companies during the 1980s and 1990s. For further information, visit the Company's web site at www.strathmoreminerals.com.

MondayNov 03, 2008 5:41 am

Sterling Resources Ltd. (TSX: SLG CN)

Sterling Resources Ltd. (TSX: SLG CN), a Calgary based energy company, is focused on exploring, developing and producing crude oil and natural gas in selected areas throughout the world. The company’s initial strategy for growth includes obtaining high initial working interests, leveraging alliances with leading UK services companies for new technology, manage financing and technical risk by obtaining industry partners, and acquiring production if it adds synergy to existing initiatives. For further information, visit the Company's web site at www.sterling-resources.com.

MondayNov 03, 2008 5:40 am

Storm Cat Energy Corporation (AMEX: SCU)

Storm Cat Energy Corporation (AMEX: SCU), an independent oil and gas company, focuses on the exploration, production and development of large unconventional gas reserves from fractured shales, coal beds, tight sand formations and from conventional formations. The company has producing properties in Wyoming's Powder River Basin, and Arkansas' Arkoma Basin and exploration and development acreage in Canada. For further information, visit the Company's web site at www.stormcatenergy.com.

Site Search

Company Search

Month: November 2008

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC)

SuperGen, Inc. (NASDAQ: SUPG)

CV Therapeutics, Inc.’s (NASDAQ: CVTX)

Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS)

Curis, Inc. (NASDAQ: CRIS)

Stroud Resources Ltd. (TSX: SDR CN)

CuraGen Corporation (NASDAQ: CRGN)

Strathmore Minerals Corp. (TSX: STM CN)

Sterling Resources Ltd. (TSX: SLG CN)

Storm Cat Energy Corporation (AMEX: SCU)

Market Basics

Newsletter Publishers

Public Companies